BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Pharm Country

  Competitive Technologies, Inc. Homocysteine Assay Patent Upheld in Re-Examination

  August 3, 2009

   · 

  1 min read
• Business

  Vical Incorporated and Teva Pharmaceutical Industries Limited Establish Sales and Marketing Agreement for Allovectin-7(r) in Israel

  August 3, 2009

   · 

  1 min read
• AusBiotech Ltd. Release: Australia Hosts International Biotechnology Showcase: Ausbiotech 2009

  August 3, 2009

   · 

  2 min read
• Drug Development

  Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma

  August 3, 2009

   · 

  4 min read
• Business

  PDL BioPharma, Inc. Elects Barry Selick to Its Board of Directors

  August 3, 2009

   · 

  1 min read
• Business

  Verenium Corporation To Announce Second Quarter 2009 Financial Results

  August 3, 2009

   · 

  3 min read
• Pharm Country

  Cegedim Dendrite Americas COO Recognized as PharmaVOICE 100 Top Executive

  August 3, 2009

   · 

  1 min read
• Drug Development

  AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

  August 3, 2009

   · 

  5 min read
• BioMidwest

  Human Genome Sciences, Inc. Announces Closing of Public Offering

  August 3, 2009

   · 

  1 min read
• Drug Development

  MDRNA, Inc. Reports Positive In Vivo Data Demonstrating That Its UsiRNAs Are Highly Potent Against Metabolic and Oncology Targets

  August 3, 2009

   · 

  4 min read